Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of refining method of gabexate mesylate

A technology of gabexate mesylate and its refining method, which is applied in the fields of chemical instruments and methods, preparation of organic compounds, organic chemistry, etc., can solve problems such as increased risk of medication, prone to hydrolysis, poor clarity, etc. The effects of small reaction, improved pH value and clarity, and simple operation

Active Publication Date: 2021-05-14
CHENGDU EASTON BIOPHARMACEUTICALS CO LTD
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] There are two ester groups and one guanidinium structure in the Gabexate molecule, which is prone to hydrolysis under the influence of acid and water, which will lead to a drop in pH value and poor clarity, increasing the risk of medication

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of refining method of gabexate mesylate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Resin pretreatment: Take 300g of commercially available macroporous adsorption resin AB-8 and 900mL of an appropriate solvent, stir and beat at room temperature for 2 hours; filter with suction, rinse the filter cake with 300mL of the corresponding solvent; put it in a decompression drying box for 35- Dry under reduced pressure at 45°C for 6 hours to obtain the pretreated macroporous adsorption resin AB-8.

[0039] Solvent handling Amount of macroporous resin after treatment yield acetone 90.00g 30.0% Acetonitrile 93.10g 31.0% Tetrahydrofuran 95.40g 31.8% ethanol 95.70g 31.9%

Embodiment 2

[0041] Add 10g of crude gabexate mesylate and 50mL of acetone to the reaction flask, raise the temperature to 55°C, and stir for 0.5 hours; add 0.1g of triethylamine and 2g of pretreated AB-8 to the reaction system, beat at 55°C for 2 hour; through a 0.2 micron membrane filter, the filtrate was stirred and crystallized at 25°C, and slurried for 0.5 hour; suction filtered, and the filter cake was dried under reduced pressure at 35°C for 8 hours to obtain the refined product of Gabexate mesylate, a white powder, The yield was 71.0%, and the purity was 99.25%. Its pH was measured to be 5.2, and its clarity in chloroform was measured, and the result was shallower than No. 0.5 turbidity standard solution.

Embodiment 3

[0043] Add 10g of crude gabexate mesylate and 50mL of acetone to the reaction flask, raise the temperature to 55°C, and stir for 0.5 hours; add 0.15g of triethylamine and 2g of pretreated AB-8 to the reaction system, beat at 55°C for 2 hour; through a 0.2 micron membrane filter, the filtrate was stirred and crystallized at 25°C, and slurried for 0.5 hour; suction filtered, and the filter cake was dried under reduced pressure at 35°C for 8 hours to obtain the refined product of Gabexate mesylate, a white powder, The yield was 69.0%, and the purity was 99.17%. Its pH was measured to be 5.2, and its clarity in chloroform was measured, and the result was shallower than No. 0.5 turbidity standard solution.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
Login to View More

Abstract

The invention provides a method for refining gabexate mesylate, said method comprising the following steps: (1) dissolving crude gabexate mesylate in an organic solvent to obtain a solution; Add alkaline reagent; (3) add macroporous adsorption resin to the solution in step (2), stir, filter membrane, filtrate cools down and crystallizes, filters, and dries to obtain refined gabexyl mesylate; wherein the alkaline reagent is Organic base or aluminum oxide. The refining method provided by the invention has controllable cost and simple operation, and the prepared gabexyl mesylate has a large improvement in pH value and clarity. The gabexyl mesylate prepared by using the refining method of the present invention The prepared freeze-dried injection has high quality and little adverse reaction.

Description

technical field [0001] The invention belongs to the field of pharmaceutical chemical preparation, and in particular relates to a method for refining gabexate mesylate. Background technique [0002] Gabexate Mesilate (Gabexate Mesilate), its chemical name is: p-(6-guanidine hexanoyloxy) ethyl benzoate mesilate; molecular formula: C 16 h 23 N 3 0 4 ·CH 4 o 3 S; molecular weight: 417.48; its structural formula is as follows: [0003] [0004] Gabexate mesylate is a non-peptide proteolytic enzyme inhibitor developed in Japan in the 1970s. In 1977, it was certified by the Special Ministry of Pharmaceuticals in Japan. It was produced and sold by Japan Ono Pharmaceutical Company in 1978. The trade name is FOY. . Gabexate mesylate has the characteristics of small molecular weight and no immunoprototype. It can inhibit the activity of proteases such as trypsin, kallikrein, plasmin and thrombin, thereby preventing the pathophysiological changes caused by these enzymes. It ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C279/14C07C277/08C07C309/04C07C303/44
Inventor 霍海建庞学海史焱王颖
Owner CHENGDU EASTON BIOPHARMACEUTICALS CO LTD